Rafael Holdings, Inc. (RFL) stock

RFLNYSEPharmaceutical PreparationsFiscal year ends July 31

Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 5/30

$1.07−0.04 (-3.60%)

Close on Nov 13, 2026Market cap $55.84MP/E –Yield –

Rafael EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Rafael has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RFL.

Revenue growth-4.7% · median -6.7%

Operating margin-3822.5% · median -2569.0%

Net margin-3390.7% · median -2511.1%

Advertisement
300 × 250

See a number that looks wrong?